At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Drug Utilization Study on the Prescribing Indications for Cyproterone Acetate and Ethinyl Estradiol in 5 European Countries
In Brief
An observational study for Hirsutism and 4 related conditions. Completed, enrolled 1,597 participants across 1 site.
Detailed Summary
This study was designed to compile the reasons and specific indications for the prescription of Cyproterone Acetate combined with Ethinyl Estradiol by Health Care Providers. The primary objective of the study was to characterize the prescribing behaviors for Cyproterone Acetate combined with Ethinyl Estradiol in 5 European countries (Austria, Czech Republic, France, the Netherlands, and Spain), including: * prescription indications for Cyproterone Acetate combined with Ethinyl Estradiol * use of Cyproterone Acetate combined with Ethinyl Estradiol in accordance with the updated label * concomitant use of Cyproterone Acetate combined with Ethinyl Estradiol and combined hormonal contraceptives * second line treatment with Cyproterone Acetate combined with Ethinyl Estradiol for the indication acne